The roles of hydrogen sulfide in renal physiology and disease states

References

• Rodrigues C, Percival SS. Immunomodulatory effects of glutathione, garlic derivatives, and hydrogen sulfide. Nutrients. 2019;11(2):295.
   PubMed Web of Science ®Google Scholar
• Warenycia MW, Goodwin LR, Benishin CG, et al. Acute hydrogen sulfide poisoning. Demonstration of selective uptake of sulfide by the brainstem by measurement of brain sulfide levels. Biochem Pharmacol. 1989;38(6):973–981.
   PubMed Web of Science ®Google Scholar
• Wedmann R, Bertlein S, Macinkovic I, et al. Working with "H2S": facts and apparent artifacts. Nitric Oxide. 2014;41:85–96.
   PubMed Web of Science ®Google Scholar
• Koning AM, Frenay AR, Leuvenink HG, et al. Hydrogen sulfide in renal physiology, disease and transplantation–the smell of renal protection. Nitric Oxide. 2015;46:37–49.
   PubMed Web of Science ®Google Scholar
• Sen N, Paul BD, Gadalla MM, et al. Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions. Mol Cell. 2012;45(1):13–24.
   PubMed Web of Science ®Google Scholar
• Feliers D, Lee HJ, Kasinath BS. Hydrogen sulfide in renal physiology and disease. Antioxid Redox Signal. 2016;25(13):720–731.
   PubMed Web of Science ®Google Scholar
• Wen YD, Wang H, Zhu YZ. The drug developments of hydrogen sulfide on cardiovascular disease. Oxid Med Cell Longev. 2018;2018:4010395.
   PubMed Web of Science ®Google Scholar
• Mathai JC, Missner A, Kügler P, et al. No facilitator required for membrane transport of hydrogen sulfide. Proc Natl Acad Sci USA. 2009;106(39):16633–16638.
   PubMed Web of Science ®Google Scholar
• Yetik-Anacak G, Sevin G, Ozzayım O, et al. Hydrogen sulfide: a novel mechanism for the vascular protection by resveratrol under oxidative stress in mouse aorta. Vascul Pharmacol. 2016;87:76–82.
   PubMed Web of Science ®Google Scholar
• Ngowi EE, Sarfraz M, Afzal A, et al. Roles of hydrogen sulfide donors in common kidney diseases. Front Pharmacol. 2020;11:564281.
   PubMed Web of Science ®Google Scholar
• Módis K, Coletta C, Erdélyi K, et al. Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. Faseb J. 2013;27(2):601–611.
   PubMed Web of Science ®Google Scholar
• Shibuya N, Koike S, Tanaka M, et al. A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat Commun. 2013;4:1366.
   PubMed Web of Science ®Google Scholar
• Paul BD, Snyder SH. H2S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol. 2012;13(8):499–507.
   PubMed Web of Science ®Google Scholar
• Mustafa AK, Gadalla MM, Sen N, et al. H2S signals through protein S-sulfhydration. Sci Signal. 2009;2(96):ra72.
   PubMed Web of Science ®Google Scholar
• Mustafa AK, Sikka G, Gazi SK, et al. Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res. 2011;109(11):1259–1268.
   PubMed Web of Science ®Google Scholar
• Krishnan N, Fu C, Pappin DJ, et al. H2S-Induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response. Sci Signal. 2011;4(203):ra86.
   PubMed Web of Science ®Google Scholar
• Xie ZZ, Shi MM, Xie L, et al. Sulfhydration of p66Shc at cysteine59 mediates the antioxidant effect of hydrogen sulfide. Antioxid Redox Signal. 2014;21(18):2531–2542.
   PubMed Web of Science ®Google Scholar
• Yang G, Zhao K, Ju Y, et al. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid Redox Signal. 2013;18(15):1906–1919.
   PubMed Web of Science ®Google Scholar
• Kamoun P. Endogenous production of hydrogen sulfide in mammals. Amino Acids. 2004;26(3):243–254.
   PubMed Web of Science ®Google Scholar
• Zhang S, Pan C, Zhou F, et al. Hydrogen sulfide as a potential therapeutic target in fibrosis. Oxid Med Cell Longev. 2015;2015:593407.
   PubMed Web of Science ®Google Scholar
• Kabil O, Vitvitsky V, Xie P, et al. The quantitative significance of the transsulfuration enzymes for H2S production in murine tissues. Antioxid Redox Signal. 2011;15(2):363–372.
   PubMed Web of Science ®Google Scholar
• Sun HJ, Wu ZY, Cao L, et al. Hydrogen sulfide: recent progression and perspectives for the treatment of diabetic nephropathy. Molecules. 2019;24(15):2857.
   PubMed Web of Science ®Google Scholar
• Xia M, Chen L, Muh RW, et al. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther. 2009;329(3):1056–1062.
   PubMed Web of Science ®Google Scholar
• Cao X, Bian JS. The role of hydrogen sulfide in renal system. Front Pharmacol. 2016;7:385.
   PubMed Web of Science ®Google Scholar
• Olson KR. Hydrogen sulfide as an oxygen sensor. Antioxid Redox Signal. 2015;22(5):377–397.
   PubMed Web of Science ®Google Scholar
• Bełtowski J. Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. J Pharmacol Exp Ther. 2010;334(2):358–363.
   PubMed Web of Science ®Google Scholar
• Teng H, Wu B, Zhao K, et al. Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease. Proc Natl Acad Sci USA. 2013;110(31):12679–12684.
   PubMed Web of Science ®Google Scholar
• Fu M, Zhang W, Wu L, et al. Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production. Proc Natl Acad Sci USA. 2012;109(8):2943–2948.
   PubMed Web of Science ®Google Scholar
• Lu M, Liu YH, Goh HS, et al. Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol. 2010;21(6):993–1002.
   PubMed Web of Science ®Google Scholar
• Liu YH, Lu M, Xie ZZ, et al. Hydrogen sulfide prevents heart failure development via inhibition of renin release from mast cells in isoproterenol-treated rats. Antioxid Redox Signal. 2014;20(5):759–769.
   PubMed Web of Science ®Google Scholar
• Huang P, Chen S, Wang Y, et al. Down-regulated CBS/H2S pathway is involved in high-salt-induced hypertension in Dahl rats. Nitric Oxide. 2015;46:192–203.
   PubMed Web of Science ®Google Scholar
• Laggner H, Hermann M, Esterbauer H, et al. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens. 2007;25(10):2100–2104.
   PubMed Web of Science ®Google Scholar
• Levey AS, James MT. Acute kidney injury. Ann Intern Med. 2017;167(9):ITC66–ITC80.
   PubMed Web of Science ®Google Scholar
• Farrar A. Acute kidney injury. Nurs Clin North Am. 2018;53(4):499–510.
   PubMed Web of Science ®Google Scholar
• Banaei S. Novel role of microRNAs in renal ischemia reperfusion injury. Ren Fail. 2015;37(7):1073–1079.
   PubMed Web of Science ®Google Scholar
• Casey TM, Arthur PG, Bogoyevitch MA. Necrotic death without mitochondrial dysfunction-delayed death of cardiac myocytes following oxidative stress. Biochim Biophys Acta. 2007;1773(3):342–351.
   PubMed Web of Science ®Google Scholar
• Han SJ, Kim JI, Park JW, et al. Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia/reperfusion injury. Nephrol Dial Transplant. 2015;30(9):1497–1506.
   PubMed Web of Science ®Google Scholar
• Bos EM, Wang R, Snijder PM, et al. Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol. 2013;24(5):759–770.
   PubMed Web of Science ®Google Scholar
• Azizi F, Seifi B, Kadkhodaee M, et al. Administration of hydrogen sulfide protects ischemia reperfusion-induced acute kidney injury by reducing the oxidative stress. Ir J Med Sci. 2016;185(3):649–654.
   PubMed Web of Science ®Google Scholar
• Verma SK, Molitoris BA. Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin Nephrol. 2015;35(1):96–107.
   PubMed Web of Science ®Google Scholar
• Snijder PM, Frenay AR, Koning AM, et al. Sodium thiosulfate attenuates angiotensin II-induced hypertension, proteinuria and renal damage. Nitric Oxide. 2014;42:87–98.
   PubMed Web of Science ®Google Scholar
• Bos EM, Leuvenink HG, Snijder PM, et al. Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol. 2009;20(9):1901–1905.
   PubMed Web of Science ®Google Scholar
• Elrod JW, Calvert JW, Morrison J, et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA. 2007;104(39):15560–15565.
   PubMed Web of Science ®Google Scholar
• Parsanathan R, Jain SK. Hydrogen sulfide increases glutathione biosynthesis, and glucose uptake and utilisation in C(2)C(12) mouse myotubes. Free Radic Res. 2018;52(2):288–303.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Olah G, Szczesny B, et al. AP39, a mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo. Shock. 2016;45(1):88–97.
   PubMed Web of Science ®Google Scholar
• Perazella MA. Drug-induced acute kidney injury: diverse mechanisms of tubular injury. Curr Opin Crit Care. 2019;25(6):550–557.
   PubMed Web of Science ®Google Scholar
• Holditch SJ, Brown CN, Lombardi AM, et al. Recent advances in models, mechanisms, biomarkers, and interventions in Cisplatin-Induced acute kidney injury. Int J Mol Sci. 2019;20(12):3011.
   PubMed Web of Science ®Google Scholar
• Manohar S, Leung N. Cisplatin nephrotoxicity: a review of the literature. J Nephrol. 2018;31(1):15–25.
   PubMed Web of Science ®Google Scholar
• Ciarimboli G. Membrane transporters as mediators of cisplatin side-effects. Anticancer Res. 2014;34(1):547–550.
   PubMedGoogle Scholar
• Tsushida K, Tanabe K, Masuda K, et al. Estrogen-related receptor α is essential for maintaining mitochondrial integrity in cisplatin-induced acute kidney injury. Biochem Biophys Res Commun. 2018;498(4):918–924.
   PubMed Web of Science ®Google Scholar
• Bajwa A, Rosin DL, Chroscicki P, et al. Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury. J Am Soc Nephrol. 2015;26(4):908–925.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li H, Su J, et al. Numb depletion promotes Drp1-Mediated mitochondrial fission and exacerbates mitochondrial fragmentation and dysfunction in acute kidney injury. Antioxid Redox Signal. 2019;30(15):1797–1816.
   PubMed Web of Science ®Google Scholar
• Yan L, Jiaqiong L, Yue G, et al. Atorvastatin protects against contrast-induced acute kidney injury via upregulation of endogenous hydrogen sulfide. Ren Fail. 2020;42(1):270–281.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhu L, Li L, et al. S-Sulfhydration of SIRT3 by hydrogen sulfide attenuates mitochondrial dysfunction in Cisplatin-induced acute kidney injury. Antioxid Redox Signal. 2019;31(17):1302–1319.
   PubMed Web of Science ®Google Scholar
• Wang T, Cao Y, Zheng Q, et al. SENP1-Sirt3 signaling controls mitochondrial protein acetylation and metabolism. Mol Cell. 2019;75(4):823–834 e5.
   PubMed Web of Science ®Google Scholar
• Gerő D, Torregrossa R, Perry A, et al. The novel mitochondria-targeted hydrogen sulfide (H(2)S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. Pharmacol Res. 2016;113(Pt A):186–198.
   PubMedGoogle Scholar
• Ahangarpour A, Abdollahzade Fard A, Gharibnaseri MK, et al. Hydrogen sulfide ameliorates the kidney dysfunction and damage in cisplatin-induced nephrotoxicity in rat. Vet Res Forum. 2014;5(2):121–127.
   PubMedGoogle Scholar
• Della Coletta Francescato H, Cunha FQ, Costa RS, et al. Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage. Nephrol Dial Transplant. 2011;26(2):479–488.
   PubMed Web of Science ®Google Scholar
• Liu M, Jia Z, Sun Y, et al. A H 2 S donor GYY4137 exacerbates Cisplatin-Induced nephrotoxicity in mice. Mediators Inflamm. 2016;2016:8145785.
   PubMed Web of Science ®Google Scholar
• Francescato HD, Marin EC, Cunha Fde Q, et al. Role of endogenous hydrogen sulfide on renal damage induced by adriamycin injection. Arch Toxicol. 2011;85(12):1597–1606.
   PubMed Web of Science ®Google Scholar
• Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–1423.
   PubMed Web of Science ®Google Scholar
• Shum HP, Yan WW, Chan TM. Recent knowledge on the pathophysiology of septic acute kidney injury: a narrative review. J Crit Care. 2016;31(1):82–89.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu W, Wang Y, et al. Hydrogen sulfide reduces kidney injury due to urinary-derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels. Exp Ther Med. 2014;8(2):464–470.
   PubMed Web of Science ®Google Scholar
• Bourque C, Zhang Y, Fu M, et al. H(2)S protects lipopolysaccharide-induced inflammation by blocking NFκB transactivation in endothelial cells. Toxicol Appl Pharmacol. 2018;338:20–29.
   PubMed Web of Science ®Google Scholar
• Li L, Bhatia M, Zhu YZ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005;19(9):1196–1198.
   PubMedGoogle Scholar
• Cao X, Xiong S, Zhou Y, et al. Renal protective effect of hydrogen sulfide in cisplatin-induced nephrotoxicity. Antioxid Redox Signal. 2018;29(5):455–470.
   PubMed Web of Science ®Google Scholar
• Sun HJ, Leng B, Wu ZY, et al. Polysulfide and hydrogen sulfide ameliorate Cisplatin-Induced nephrotoxicity and renal inflammation through persulfidating STAT3 and IKKβ. Int J Mol Sci. 2020;21(20):7805.
   PubMed Web of Science ®Google Scholar
• Chen Y, Jin S, Teng X, et al. Hydrogen sulfide attenuates LPS-Induced acute kidney injury by inhibiting inflammation and oxidative stress. Oxid Med Cell Longev. 2018;2018:6717212.
   PubMed Web of Science ®Google Scholar
• Li T, Zhao J, Miao S, et al. Protective effect of H(2)S on LPS‑induced AKI by promoting autophagy. Mol Med Rep. 2022;25(3)
   Web of Science ®Google Scholar
• Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39(1–3):84–92.
   PubMed Web of Science ®Google Scholar
• Girndt M. Diagnosis and treatment of chronic kidney disease. Internist. 2017;58(3):243–256.
   PubMed Web of Science ®Google Scholar
• Padmanabhan A, Gohil S, Gadgil NM, et al. Chronic renal failure: an autopsy study. Saudi J Kidney Dis Transpl. 2017;28(3):545–551.
   PubMedGoogle Scholar
• Lian Y, Xie L, Chen M, et al. Effects of an astragalus polysaccharide and rhein combination on apoptosis in rats with chronic renal failure. Evid Based Complement Alternat Med. 2014;2014:271862.
   PubMed Web of Science ®Google Scholar
• Shirazi MK, Azarnezhad A, Abazari MF, et al. The role of nitric oxide signaling in renoprotective effects of hydrogen sulfide against chronic kidney disease in rats: involvement of oxidative stress, autophagy and apoptosis. J Cell Physiol. 2019;234(7):11411–11423.
   PubMed Web of Science ®Google Scholar
• Perna AF, Lanza D, Sepe I, et al. Vasodilatation caused by endogenous hydrogen sulfide in chronic renal failure. G Ital Nefrol. 2013;30(2):gin/30.2.2.
   PubMedGoogle Scholar
• Aminzadeh MA, Vaziri ND. Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. Nephrol Dial Transplant. 2012;27(2):498–504.
   PubMed Web of Science ®Google Scholar
• Askari H, Seifi B, Kadkhodaee M, et al. Protective effects of hydrogen sulfide on chronic kidney disease by reducing oxidative stress, inflammation and apoptosis. Excli J. 2018;17:14–23.
   PubMed Web of Science ®Google Scholar
• Wu D, Si W, Wang M, et al. Hydrogen sulfide in cancer: friend or foe? Nitric Oxide. 2015;50:38–45.
   PubMed Web of Science ®Google Scholar
• Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48(6):749–762.
   PubMed Web of Science ®Google Scholar
• Tu Y, Sun W, Wan YG, et al. Dahuang Fuzi decoction ameliorates tubular epithelial apoptosis and renal damage via inhibiting TGF-β1-JNK signaling pathway activation in vivo. J Ethnopharmacol. 2014;156:115–124.
   PubMed Web of Science ®Google Scholar
• Ford A, Al-Magableh M, Gaspari TA, et al. Chronic NaHS treatment is vasoprotective in High-Fat-Fed ApoE(–/–) mice. Int J Vasc Med. 2013;2013:915983.
   PubMedGoogle Scholar
• Wu D, Luo N, Wang L, et al. Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ROS/MAPK and NF-κB signaling pathways. Sci Rep. 2017;7(1):455.
   PubMedGoogle Scholar
• Migdalis I, Leslie D, Mavrogiannaki A, et al. Diabetes mellitus 2014. Int J Endocrinol. 2015;2015:845759.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med. 2010;268(5):456–467.
   PubMed Web of Science ®Google Scholar
• Stanton RC. Oxidative stress and diabetic kidney disease. Curr Diab Rep. 2011;11(4):330–336.
   PubMed Web of Science ®Google Scholar
• Tesch GH, Lim AK. Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy. Am J Physiol Renal Physiol. 2011;300(2):F301–10.
   PubMed Web of Science ®Google Scholar
• Lim AK, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inflamm. 2012;2012:146154.
   PubMed Web of Science ®Google Scholar
• Kamiyama M, Zsombok A, Kobori H. Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes. J Pharmacol Sci. 2012;119(4):314–323.
   PubMed Web of Science ®Google Scholar
• Jain SK, Bull R, Rains JL, et al. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal. 2010;12(11):1333–1337.
   PubMed Web of Science ®Google Scholar
• van den Born JC, Frenay AR, Bakker SJ, et al. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes. Nitric Oxide. 2016;55-56:18–24.
   PubMed Web of Science ®Google Scholar
• Li H, Feng SJ, Zhang GZ, et al. Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy. Blood Purif. 2014;38(3–4):188–194.
   PubMed Web of Science ®Google Scholar
• Xue R, Hao DD, Sun JP, et al. Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes. Antioxid Redox Signal. 2013;19(1):5–23.
   PubMed Web of Science ®Google Scholar
• Sun HJ, Xiong SP, Cao X, et al. Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3. Redox Biol. 2021;38:101813.
   PubMed Web of Science ®Google Scholar
• Yu Y, Xiao L, Ren Z, et al. Glucose-induced decrease of cystathionine β-synthase mediates renal injuries. Faseb J. 2021;35(5):e21576.
   PubMed Web of Science ®Google Scholar
• Hussain Lodhi A, Ahmad FU, Furwa K, et al. Role of oxidative stress and reduced endogenous hydrogen sulfide in diabetic nephropathy. Drug Des Devel Ther. 2021;15:1031–1043.
   PubMed Web of Science ®Google Scholar
• Juin SK, Pushpakumar S, Sen U. GYY4137 regulates extracellular matrix turnover in the diabetic kidney by modulating retinoid X receptor signaling. Biomolecules. 2021;11(10):1477.
   PubMed Web of Science ®Google Scholar
• Elbassuoni EA, Аziz NM, Habeeb WN. The role of activation of K(АTP) channels on hydrogen sulfide induced renoprotective effect on diabetic nephropathy. J Cell Physiol. 2020;235(6):5223–5228.
   PubMed Web of Science ®Google Scholar
• Qian X, Li X, Ma F, et al. Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy. Biochem Biophys Res Commun. 2016;473(4):931–938.
   PubMed Web of Science ®Google Scholar
• Ahmed HH, Taha FM, Omar HS, et al. Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy. Mol Cell Biochem. 2019;457(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Li Y, Li L, Zeng O, et al. H(2)S improves renal fibrosis in STZ-induced diabetic rats by ameliorating TGF-β1 expression. Ren Fail. 2017;39(1):265–272.
   PubMed Web of Science ®Google Scholar
• Kumawat M, Sharma TK, Singh I, et al. Antioxidant enzymes and lipid peroxidation in type 2 diabetes mellitus patients with and without nephropathy. N Am J Med Sci. 2013;5(3):213–219.
   PubMedGoogle Scholar
• Mima A. Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets. J Diabetes Res. 2013;2013:248563.
   PubMed Web of Science ®Google Scholar
• Eid AA, Gorin Y, Fagg BM, et al. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes. 2009;58(5):1201–1211.
   PubMed Web of Science ®Google Scholar
• Zhang MH, Feng L, Zhu MM, et al. Antioxidative and anti-inflammatory activities of paeoniflorin and oxypaeoniflora on AGEs-induced mesangial cell damage. Planta Med. 2013;79(14):1319–1323.
   PubMed Web of Science ®Google Scholar
• Safar MM, Abdelsalam RM. H2S donors attenuate diabetic nephropathy in rats: modulation of oxidant status and polyol pathway. Pharmacol Rep. 2015;67(1):17–23.
   PubMed Web of Science ®Google Scholar
• Yang R, Liu XF, Ma SF, et al. Protective effect of hydrogen sulfide on kidneys of type 1 diabetic rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2016;32(2):181–184.
   PubMedGoogle Scholar
• Wei Y, Gong J, Thimmulappa RK, et al. Nrf2 acts cell-autonomously in endothelium to regulate tip cell formation and vascular branching. Proc Natl Acad Sci USA. 2013;110(41):E3910–8.
   PubMed Web of Science ®Google Scholar
• Zheng H, Whitman SA, Wu W, et al. Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes. 2011;60(11):3055–3066.
   PubMed Web of Science ®Google Scholar
• Xie L, Gu Y, Wen M, et al. Hydrogen sulfide induces Keap1 S-sulfhydration and suppresses diabetes-accelerated atherosclerosis via Nrf2 activation. Diabetes. 2016;65(10):3171–3184.
   PubMed Web of Science ®Google Scholar
• Zhou X, Feng Y, Zhan Z, et al. Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model. J Biol Chem. 2014;289(42):28827–28834.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee DY, Mariappan MM, et al. Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells. J Biol Chem. 2017;292(14):5665–5675.
   PubMed Web of Science ®Google Scholar
• Gorin Y, Block K. Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? Free Radic Biol Med. 2013;61:130–142.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Feliers D, Mariappan MM, et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol. 2007;292(2):F617–27.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Mariappan MM, Feliers D, et al. Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells. J Biol Chem. 2012;287(7):4451–4461.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42.
   PubMed Web of Science ®Google Scholar
• Li L, Tan J, Miao Y, et al. ROS and autophagy: interactions and molecular regulatory mechanisms. Cell Mol Neurobiol. 2015;35(5):615–621.
   PubMed Web of Science ®Google Scholar
• Liu J, Wu J, Sun A, et al. Hydrogen sulfide decreases high glucose/palmitate-induced autophagy in endothelial cells by the Nrf2-ROS-AMPK signaling pathway. Cell Biosci. 2016;6(1):33.
   PubMedGoogle Scholar
• Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011;12(5):3117–3132.
   PubMed Web of Science ®Google Scholar
• Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond). 2013;124(3):139–152.
   PubMed Web of Science ®Google Scholar
• Wang W, Sun W, Cheng Y, et al. Role of sirtuin-1 in diabetic nephropathy. J Mol Med. 2019;97(3):291–309.
   PubMed Web of Science ®Google Scholar
• Naduk-Kik J, Hrabec E. The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy. Postepy Hig Med Dosw. 2008;62:442–450.
   Web of Science ®Google Scholar
• Kundu S, Pushpakumar SB, Tyagi A, et al. Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9. Am J Physiol Endocrinol Metab. 2013;304(12):E1365–78.
   PubMed Web of Science ®Google Scholar
• Patel S, Rauf A, Khan H, et al. Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed Pharmacother. 2017;94:317–325.
   PubMed Web of Science ®Google Scholar
• Thomas MC, Brownlee M, Susztak K, et al. Diabetic kidney disease. Nat Rev Dis Primers. 2015;1:15018.
   PubMed Web of Science ®Google Scholar
• Bermejo S, García CO, Rodríguez E, et al. The renin-angiotensin-aldosterone system blockade in patients with advanced diabetic kidney disease. Nefrologia. 2018;38(2):197–206.
   PubMed Web of Science ®Google Scholar
• Li Z, Organ CL, Kang J, et al. Hydrogen sulfide attenuates renin angiotensin and aldosterone pathological signaling to preserve kidney function and improve exercise tolerance in heart failure. JACC Basic Transl Sci. 2018;3(6):796–809.
   PubMedGoogle Scholar
• Xue H, Yuan P, Ni J, et al. H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation. PLoS One. 2013;8(9):e74366.
   PubMed Web of Science ®Google Scholar
• Hart PD, Bakris GL. Hypertensive nephropathy: prevention and treatment recommendations. Expert Opin Pharmacother. 2010;11(16):2675–2686.
   PubMed Web of Science ®Google Scholar
• Udani S, Lazich I, Bakris GL. Epidemiology of hypertensive kidney disease. Nat Rev Nephrol. 2011;7(1):11–21.
   PubMed Web of Science ®Google Scholar
• Seccia TM, Caroccia B, Calò LA. Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms. J Hypertens. 2017;35(2):205–212.
   PubMed Web of Science ®Google Scholar
• Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44(5):595–601.
   PubMed Web of Science ®Google Scholar
• Yang G, Wu L, Jiang B, et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science. 2008;322(5901):587–590.
   PubMed Web of Science ®Google Scholar
• Roy A, Khan AH, Islam MT, et al. Interdependency of cystathione γ-lyase and cystathione β-synthase in hydrogen sulfide-induced blood pressure regulation in rats. Am J Hypertens. 2012;25(1):74–81.
   PubMed Web of Science ®Google Scholar
• Zhao W, Wang R. H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol. 2002;283(2):H474–80.
   PubMed Web of Science ®Google Scholar
• Gross B, Pawlak M, Lefebvre P, et al. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol. 2017;13(1):36–49.
   PubMed Web of Science ®Google Scholar
• Toral M, Romero M, Pérez-Vizcaíno F, et al. Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation. Am J Physiol Heart Circ Physiol. 2017;312(2):H189–H200.
   PubMed Web of Science ®Google Scholar
• Predmore BL, Julian D, Cardounel AJ. Hydrogen sulfide increases nitric oxide production from endothelial cells by an akt-dependent mechanism. Front Physiol. 2011;2:104.
   PubMed Web of Science ®Google Scholar
• Xiao L, Dong JH, Teng X, et al. Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor Delta/endothelial nitric oxide synthase signaling. J Hypertens. 2018;36(3):651–665.
   PubMed Web of Science ®Google Scholar
• Ji W, Liu S, Dai J, et al. Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway. Chin Med J. 2014;127(21):3751–3757.
   PubMed Web of Science ®Google Scholar
• Ali MY, Ping CY, Mok YY, et al. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol. 2006;149(6):625–634.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega M, Esteban V, Rupérez M, et al. Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens. 2006;15(2):159–166.
   PubMed Web of Science ®Google Scholar
• Liao TD, Yang XP, Liu YH, et al. Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Hypertension. 2008;52(2):256–263.
   PubMed Web of Science ®Google Scholar
• Al-Magableh MR, Kemp-Harper BK, Hart JL. Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice. Hypertens Res. 2015;38(1):13–20.
   PubMed Web of Science ®Google Scholar
• Stevens S. Obstructive kidney disease. Nurs Clin North Am. 2018;53(4):569–578.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhu X, Wang X, et al. H(2)S alleviates renal injury and fibrosis in response to unilateral ureteral obstruction by regulating macrophage infiltration via inhibition of NLRP3 signaling. Exp Cell Res. 2020;387(1):111779.
   PubMed Web of Science ®Google Scholar
• Jung KJ, Jang HS, Kim JI, et al. Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction. Biochim Biophys Acta. 2013;1832(12):1989–1997.
   PubMed Web of Science ®Google Scholar
• Song K, Wang F, Li Q, et al. Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy. Kidney Int. 2014;85(6):1318–1329.
   PubMed Web of Science ®Google Scholar
• Lin S, Visram F, Liu W, et al. GYY4137, a slow-releasing hydrogen sulfide donor, ameliorates renal damage associated with chronic obstructive uropathy. J Urol. 2016;196(6):1778–1787.
   PubMed Web of Science ®Google Scholar
• Lin S, Lian D, Liu W, et al. Daily therapy with a slow-releasing H(2)S donor GYY4137 enables early functional recovery and ameliorates renal injury associated with urinary obstruction. Nitric Oxide. 2018;76:16–28.
   PubMed Web of Science ®Google Scholar
• Jiang D, Zhang Y, Yang M, et al. Exogenous hydrogen sulfide prevents kidney damage following unilateral ureteral obstruction. Neurourol Urodyn. 2014;33(5):538–543.
   PubMed Web of Science ®Google Scholar
• Dursun M, Otunctemur A, Ozbek E, et al. Protective effect of hydrogen sulfide on renal injury in the experimental unilateral ureteral obstruction. Int Braz j Urol. 2015;41(6):1185–1193.
   PubMed Web of Science ®Google Scholar
• Chen Q, Yu S, Zhang K, et al. Exogenous H2S inhibits autophagy in unilateral ureteral obstruction mouse renal tubule cells by regulating the ROS-AMPK signaling pathway. Cell Physiol Biochem. 2018;49(6):2200–2213.
   PubMedGoogle Scholar
• Song K, Li Q, Yin X-Y, et al. Hydrogen sulfide: a therapeutic candidate for fibrotic disease? Oxid Med Cell Longev. 2015;2015:458720.
   PubMed Web of Science ®Google Scholar
• Duni A, Liakopoulos V, Roumeliotis S, et al. Oxidative stress in the pathogenesis and evolution of chronic kidney disease: untangling Ariadne’s thread. Int J Mol Sci. 2019;20(15):3711.
   PubMed Web of Science ®Google Scholar
• Xu W, Chen J, Lin J, et al. Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways. Int J Mol Med. 2015;35(1):177–186.
   PubMed Web of Science ®Google Scholar
• Orecchioni M, Ghosheh Y, Pramod AB, et al. Macrophage polarization: different gene signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Front Immunol. 2019;10:1084.
   PubMed Web of Science ®Google Scholar
• Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44(3):450–462.
   PubMed Web of Science ®Google Scholar
• Chakarov S, Lim HY, Tan L, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363(6432):aau0964.
   Web of Science ®Google Scholar
• Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27:451–483.
   PubMed Web of Science ®Google Scholar
• Lin S, Juriasingani S, Sener A. Is hydrogen sulfide a potential novel therapy to prevent renal damage during ureteral obstruction? Nitric Oxide. 2018;73:15–21.
   PubMed Web of Science ®Google Scholar
• Szabo C, Papapetropoulos A. International union of basic and clinical pharmacology. CII: pharmacological modulation of H(2)S levels: H(2)S donors and H(2)S biosynthesis inhibitors. Pharmacol Rev. 2017;69(4):497–564.
   PubMed Web of Science ®Google Scholar
• Powell CR, Dillon KM, Matson JB. A review of hydrogen sulfide (H(2)S) donors: chemistry and potential therapeutic applications. Biochem Pharmacol. 2018;149:110–123.
   PubMed Web of Science ®Google Scholar
• Hughes MN, Centelles MN, Moore KP. Making and working with hydrogen sulfide: the chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review. Free Radic Biol Med. 2009;47(10):1346–1353.
   PubMed Web of Science ®Google Scholar
• Gomez CB, de la Cruz SH, Medina-Terol GJ, et al. Chronic administration of NaHS and L-cysteine restores cardiovascular changes induced by high-fat diet in rats. Eur J Pharmacol. 2019;863:172707.
   PubMed Web of Science ®Google Scholar
• Melino S, Leo S, Toska Papajani V. Natural hydrogen sulfide donors from allium sp. as a nutraceutical approach in type 2 diabetes prevention and therapy. Nutrients. 2019;11(7):1581.
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Distrutti E. COXIBs, CINODs and H2S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs. Curr Med Chem. 2011;18(23):3494–3505.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Caliendo G, Santagada V, et al. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br J Pharmacol. 2010;159(6):1236–1246.
   PubMed Web of Science ®Google Scholar
• Polhemus DJ, Li Z, Pattillo CB, et al. A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients. Cardiovasc Ther. 2015;33(4):216–226.
   PubMed Web of Science ®Google Scholar
• Wang Y, Qu R, Hu S, et al. Upregulation of cystathionine β-synthetase expression contributes to visceral hyperalgesia induced by heterotypic intermittent stress in rats. PLoS One. 2012;7(12):e53165.
   PubMed Web of Science ®Google Scholar
• Krause NC, Kutsche HS, Santangelo F, et al. Hydrogen sulfide contributes to hypoxic inhibition of airway transepithelial sodium absorption. Am J Physiol Regul Integr Comp Physiol. 2016;311(3):R607–17.
   PubMed Web of Science ®Google Scholar
• Asimakopoulou A, Panopoulos P, Chasapis CT, et al. Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE). Br J Pharmacol. 2013;169(4):922–932.
   PubMed Web of Science ®Google Scholar
• Nespoux J, Vallon V. SGLT2 inhibition and kidney protection. Clin Sci. 2018;132(12):1329–1339.
   PubMed Web of Science ®Google Scholar